IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.54%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$217M
AUM Growth
+$217M
(+1.5%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
41.84%
Holding
98
New
28
Increased
15
Reduced
17
Closed
18
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$11M |
| 2 |
Elevance Health
ELV
|
$9.19M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.84M |
| 4 |
Gilead Sciences
GILD
|
$4.17M |
| 5 |
Illumina
ILMN
|
$3.51M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.4M |
| 2 |
Cigna
CI
|
$13.7M |
| 3 |
Medtronic
MDT
|
$7.5M |
| 4 |
Baxter International
BAX
|
$7.01M |
| 5 |
Eli Lilly
LLY
|
$5.4M |
Sector Composition
| 1 | Healthcare | 88.35% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alkermes
ALKS
$4.78B
| $1.3M | 0.53% |
+30,000
| New | +$1.3M |
|
52
Minerva Neurosciences
NERV
$16.5M
| $1.28M | 0.52% |
+125,000
| New | +$1.28M |
|
53
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.27M | 0.52% |
75,000
-25,000
| -25% | -$422K |
|
|
WBA
54
DELISTED
Walgreens Boots Alliance
WBA
| $1.25M | 0.51% |
+15,000
| New | +$1.25M |
|
|
CLVS
55
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | 0.5% |
+90,000
| New | +$1.24M |
|
56
Viatris
VTRS
$12.3B
| $1.08M | 0.44% |
+25,000
| New | +$1.08M |
|
|
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $971K | 0.4% |
25,000
-25,000
| -50% | -$971K |
|
|
AVDL
58
Avadel Pharmaceuticals
AVDL
$1.43B
| $806K | 0.33% |
+75,000
| New | +$806K |
|
59
ADMA Biologics
ADMA
$4.12B
| $744K | 0.3% |
+125,000
| New | +$744K |
|
60
Sangamo Therapeutics
SGMO
$157M
| $724K | 0.29% |
125,000
+50,000
| +67% | +$290K |
|
61
Pacific Biosciences
PACB
$393M
| $704K | 0.29% |
100,000
+25,000
| +33% | +$176K |
|
|
CCXI
62
DELISTED
ChemoCentryx, Inc.
CCXI
| $674K | 0.27% |
+150,000
| New | +$674K |
|
|
GI
63
DELISTED
EndoChoice Holdings, Inc.
GI
| $613K | 0.25% |
125,000
+10,000
| +9% | +$49K |
|
|
MDVN
64
DELISTED
MEDIVATION, INC.
MDVN
| $603K | 0.25% |
10,000
-255,000
| -96% | -$15.4M |
|
65
Clearside Biomedical
CLSD
$28.9M
| $526K | 0.21% |
+75,015
| New | +$526K |
|
|
IMMU
66
DELISTED
Immunomedics Inc
IMMU
| $522K | 0.21% |
+225,000
| New | +$522K |
|
67
Standard BioTools
LAB
$481M
| $452K | 0.18% |
50,000
-50,000
| -50% | -$452K |
|
68
Rigel Pharmaceuticals
RIGL
$697M
| $335K | 0.14% |
+150,000
| New | +$335K |
|
69
SCYNEXIS
SCYX
$34.9M
| $271K | 0.11% |
125,000
| – | – |
|
70
AbbVie
ABBV
$372B
| – | – |
0
| – | – |
|
71
Brookdale Senior Living
BKD
$1.83B
| – | – |
-125,000
| Closed | -$1.99M |
|
|
BLUE
72
DELISTED
bluebird bio
BLUE
| – | – |
-25,000
| Closed | -$1.06M |
|
73
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-30,000
| Closed | -$2.47M |
|
74
Bristol-Myers Squibb
BMY
$96B
| – | – |
0
| – | – |
|
|
75
Cigna
CI
$80.3B
| – | – |
-100,000
| Closed | -$13.7M |
|